Encompass Health Corporation Financials

Market Capitalization $11.98 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	24.46
Forward PE	24.87
Price to Sales TTM	$2.17
Price to Book MRQ	$5.56
Enterprise to Revenue	2.86
Enterprise to EBITDA	12.78

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	8.97%
Operating Margin	18.35%
Return on Assets TTM	8.97%
Return on Equity TTM	24.58%

Income Statement

Revenue TTM	$5,512,600,064
Revenue per Share TTM	$55.09
Quarterly Revenue Growth	10.60%
Gross Profit TTM	$2,318,200,064
EBITDA	$1,252,900,000
Net Income to Common TTM	$494,300,000
Diluted EPS TTM	$4.86
Quarterly Earnings Growth YoY	34.70%

Balance Sheet

Total Cash MRQ	$95,800,000
Total Cash per Share MRQ	$0.95
Total Debt MRQ	$
Total Debt to Equity MRQ	92.01
Current Ratio MRQ	1.06
Book Value per Share MRQ	$21.40

Cash Flow

Operating Cash Flow TTM	$1,052,600,000
Levered Free Cash Flow TTM	$235,850,000

EHC Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	100,775,364
Float Shares	99,408,951
Avg 10 Volume	741,084
Avg 30 Volume	None
Shares Short	844,312
Short Ratio	1.29
Short % of Shares	0.94%
% Held by Insiders	1.41%
% Held by Institutions	97.85%

Stock Price Summary

Beta	0.77
Fifty Two Week Low	$82.74
Fifty Two Week High	$123.13
Fifty Two Week Change	28.39%
Day 50 MA	$117.69
Day 200 MA	$102.83

Dividends and Splits

Forward Annual Dividend Rate	$0.68
Forward Annual Dividend Yield	0.57%
Trailing Annual Dividend Rate	$0.66
Trailing Annual Dividend Yield	0.55%
Payout Ratio	13.58%
Dividend Date	2025-07-15
Ex Dividend Date	2025-07-01
Last Split Factor
Last Split Date	2022-07-01